Clinical Trials Logo

Hypoglycemia clinical trials

View clinical trials related to Hypoglycemia.

Filter by:

NCT ID: NCT01005342 Completed - Hyperglycemia Clinical Trials

Influence of Dietary Fiber-rich Meals on Gene Expression and Postprandial Glucose and Lipid Response

Start date: May 2007
Phase: N/A
Study type: Interventional

The aim of this study is to - Measure the effect on gene expression in leukocytes from a meal rich in oat bran - Investigate the postprandial glucose, insulin and triglyceride responses after intake of meals containing fiber from different sources (oat, rye and sugar beet fiber) or a meal containing a mixture of these three fibers

NCT ID: NCT00998374 Completed - Obesity Clinical Trials

Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge

Start date: September 2009
Phase: N/A
Study type: Observational

This study will compare glucose and simple carbohydrate sensitivity. The hypothesis is that rapid emptying of high-glycemic index foods after Roux-En-Y gastric bypass (RYGB) causes reactive hypoglycemia. It is believed that the controlled release offered by an intact pylorus will be advantageous for long term results in bariatric surgery. This study can provide a scientific rationale, in a short duration of time, for why pylorus sparing surgery, such as the sleeve gastrectomy or duodenal switch, may offer therapeutic advantages, as compared to non-pyloric sparing surgery, namely the gastric bypass.

NCT ID: NCT00993720 Completed - Diabetes Mellitus Clinical Trials

Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes

Start date: October 2009
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of the study is to investigate the effect of Victoza (a GLP-1 receptor agonist)on insulin-dose, risk of hypoglycemia and gastric emptying rate during hypoglycemia in patients with type 1 diabetes.

NCT ID: NCT00974051 Completed - Type 1 Diabetes Clinical Trials

Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia

Start date: March 2008
Phase: N/A
Study type: Interventional

The investigators hypothesize that the use of an oral dose of Terbutaline or a 20% basal reduction will be able to prevent nocturnal hypoglycemia after an afternoon exercise session. This is a randomized three period cross-over study including treatment with Terbutaline, a 20% basal reduction for six hours, or no treatment (control).

NCT ID: NCT00937079 Completed - Hypoglycemia Clinical Trials

Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients

Start date: November 2007
Phase: Phase 1
Study type: Observational

The purpose of this study is to determine whether the investigators' new imaging modality (111In-exendin-4) has advantages in detecting insulinomas in comparison to conventional imaging.

NCT ID: NCT00916838 Completed - Clinical trials for Type 1 Diabetes Mellitis

Neurocognitive Impact of Hypoglycemia in Type 1 Diabetes

HYPO
Start date: January 2003
Phase:
Study type: Observational

125 children with Type 1 Diabetes mellitis (T1DM) between 4 and 16 were recruited and 62 healthy siblings also enrolled in the study. Children with T1DM and sibling controls ages 4 to 16 were assessed on memory and executive control skills at entry to the study (Test 1) and after two years of close monitoring for blood sugar events (Test 2). Diabetic children have their blood sugar tested directly before and after cognitive testing to ensure their blood sugar is within range during the testing. The 2-year follow-up period involves parents/child reporting any severe diabetic episode and periodically providing the results of the diabetic child's usual blood tests from their glucose monitoring device. Children 7 and older also underwent high resolution MRI scans.

NCT ID: NCT00907881 Completed - Type 2 Diabetes Clinical Trials

The OBSTACLE Hypoglycemia Study (MK-0000-158)

Start date: August 2009
Phase: N/A
Study type: Observational

This study will assess the correlation between glycemic control and the hypoglycemia symptom score in patients with Type 2 diabetes, 12 weeks after addition of a sulfonylurea to an ongoing regime of oral hypoglycemic agents.

NCT ID: NCT00882492 Completed - Hyperglycemia Clinical Trials

GLP 1 for Intraoperative Glycemic Control

GLP
Start date: December 2008
Phase: Phase 1
Study type: Interventional

This is a medical research study designed to see if an infusion of a naturally occurring hormone, GLP-1, works when used to decrease blood sugar during cardiac surgery.

NCT ID: NCT00882050 Completed - Hyperglycemia Clinical Trials

Intravenous Exenatide (Byetta) During Surgery

Start date: March 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this project is to study if intravenous Exenatide is effective at maintaining normal blood glucose levels and preventing low blood glucose levels during surgery.

NCT ID: NCT00847080 Completed - Clinical trials for Reactive Hypoglycemia

Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism

Start date: December 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether sitagliptin is effective in the treatment of reactive hypoglycemia by dysinsulinism.